AI assistant
Sending…
Pacira BioSciences, Inc. — Director's Dealing 2021
Dec 20, 2021
32125_dirs_2021-12-20_95da1aa6-0103-4918-a58e-b55e88a8121e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pacira BioSciences, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2021-12-17
Reporting Person: Froimson Mark (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-17 | Common Stock | G | 400 | $0.00 | Disposed | 5908 | Direct |
More from Pacira BioSciences, Inc.
Proxy Solicitation & Information Statement
2026
Jun 1
Proxy Solicitation & Information Statement
2026
May 28
Proxy Solicitation & Information Statement
2026
May 27
Proxy Solicitation & Information Statement
2026
May 26
Proxy Solicitation & Information Statement
2026
May 20
Proxy Solicitation & Information Statement
2026
May 19
Proxy Solicitation & Information Statement
2026
May 13
Proxy Solicitation & Information Statement
2026
May 12
Interim / Quarterly Report
2026
Apr 30
Annual Report
2026
Apr 28